$MX

MAGNACHIP SEMICONDUCTOR Corp (MX): Results of Operations and Financial Condition

MAGNACHIP SEMICONDUCTOR Corp (MX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Magnachip Reports Results for Second Quarter 2026 Q2 Results Summary • Consolidated revenue from continuing operations (which includes Power Analog Solutions (“PAS”) and Power IC (“PIC”) businesses) was $44.7 million, within th

Original reporting
Published Jul 29, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MX
Neutral
high confidence
Mentioned
$MX
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MXNeutralMed
01

Why it matters

Traders can update models for MX’s near-term revenue trajectory and margin outlook using the provided Q3 ranges and the stated drivers (product mix, packaging constraints, and pricing pressure on legacy products).

02

Market read

The filing is a primary earnings-and-guidance disclosure with explicit Q3 revenue and gross margin ranges plus near-term operational constraints that can drive trading sentiment.

03

What to watch

Q3 revenue decline is attributed to near-term packaging constraints and customer volume softness in certain consumer applications, which may be temporary versus structural demand weakness.

Relevance 7/10Novelty 8/10Timing: after-hours guidance and Q2 results release (SEC 8-K filed July 29, 2026)

Background

The 8-K includes Item 2.02 results and an attached earnings release with Q2 2026 financials, recent operational highlights (CEO appointment, 600V SJ MOSFET launch, Navitas SiC licensing partnership), and Q3 2026 guidance.

Company-level read

Ticker impact

$MXNeutralHigh confidence
Context

Magnachip reported Q2 2026 revenue of $44.7M within guidance and guided Q3 revenue to $41.5M-$45.5M with 17%-19% gross margin.

Expected impact

Likely near-term volatility around the Q3 revenue and gross margin range, with downside risk if investors focus on sequential decline and supply-chain packaging constraints.

Evidence & confidence

The filing provides specific GAAP and non-GAAP results, a Q3 revenue range, and explicit drivers for sequential revenue decline (packaging constraints, lower consumer volumes, unfavorable mix).

Market effects

Signals demand and pricing pressure dynamics in power semiconductor end-markets (mobile battery FETs, legacy products) and highlights SiC technology licensing momentum.

Limited direct regional read-through beyond South Korea-based issuer execution and manufacturing constraints.

Relevant to global power semiconductor supply chains via packaging constraints and SiC technology licensing for high-voltage markets.

Counterpoint

Investors may underweight the sequential revenue decline because Q2 gross margin exceeded the top end of guidance and the Navitas SiC partnership could improve product differentiation over time.

Key entities

  • Magnachip Semiconductor Corporation

    Reports Q2 2026 results, appoints CEO Chae Lee, launches 6th-gen 600V SJ MOSFETs, partners with Navitas for SiC licensing, and issues Q3 2026 guidance.

  • Chae Lee

    Appointed Chief Executive Officer, commenting on the strategic relationship with Navitas and the rebuild plan.

  • Navitas Semiconductor

    Strategic partnership to license SiC technology for high-voltage and ultra-high-voltage power markets.

Related articles

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.